PMID- 16788526
OWN - NLM
STAT- MEDLINE
DCOM- 20060912
LR  - 20191026
IS  - 0761-8425 (Print)
IS  - 0761-8425 (Linking)
VI  - 23
IP  - 3 Pt 1
DP  - 2006 Jun
TI  - [Economic analysis of home based versus hospital outpatient chemotherapy in stage 
      IV non small cell lung cancer].
PG  - 255-63
AB  - BACKGROUND: French law and government decisions have induced new development for 
      home base treatments. The objective was to compare cost of home base chemotherapy 
      (HBC) versus outpatient infusions, for non small cell lung cancer (NSCLC). 
      METHODS: 10 patients were selected in each category. D8 of their cycles was 
      performed at home compared to outpatient infusion. Costs were based on national 
      fees with cytostatic drugs as supplement. The real cost was also assessed through 
      a specific questionnaire. RESULTS: 30 D8 infusions were carried out at hospital 
      and 24 D8 infusions at home. Average cost by cycle was 2,829.51 euros [2 560.74-3 
      147.02] for hospital infusion, 2,372.50 euros [1 962.75-2 792.88] for HBC 
      (-16.15%). Difference was -457.01 euros by cycle [-919.74; 26.82]. Real costs by 
      injection for BHC was 484.42 euros [424.18; 540.32] versus a fee of 699.89 euros 
      [643.64; 750.23]. There were no difference in terms of adverse events. 
      CONCLUSION: HBC for NSCLC is feasible. Average costs by cycle is lower of 16% 
      versus hospital infusion. The results of this non randomized study had to be 
      confirm by further clinical trials.
FAU - Vergnenegre, A
AU  - Vergnenegre A
AD  - Service de l'Information Medicale et de l'Evaluation, Hopital du Cluzeau, CHU de 
      Limoges, France. alain.vergnenegre@unilim.fr
FAU - Decroisette, C
AU  - Decroisette C
FAU - Vincent, F
AU  - Vincent F
FAU - Dalmay, F
AU  - Dalmay F
FAU - Melloni, B
AU  - Melloni B
FAU - Bonnaud, F
AU  - Bonnaud F
FAU - Eichler, B
AU  - Eichler B
LA  - fre
PT  - Comparative Study
PT  - English Abstract
PT  - Journal Article
TT  - Analyse economique de l'administration d'une chimiotherapie en hospitalisation a 
      domicile (HAD) comparee a l'hospitalisation de jour dans les cancers 
      bronchopulmonaires non a petites cellules de stade IV.
PL  - France
TA  - Rev Mal Respir
JT  - Revue des maladies respiratoires
JID - 8408032
SB  - IM
CIN - Rev Mal Respir. 2006 Jun;23(3 Pt 1):207-8. PMID: 16788519
MH  - Ambulatory Care/economics
MH  - Antineoplastic Combined Chemotherapy Protocols/*economics/*therapeutic use
MH  - Carcinoma, Non-Small-Cell Lung/*drug therapy/pathology
MH  - France
MH  - Home Care Services/*economics
MH  - Humans
MH  - Infusions, Intravenous
MH  - Lung Neoplasms/*drug therapy/pathology
MH  - Middle Aged
EDAT- 2006/06/22 09:00
MHDA- 2006/09/13 09:00
CRDT- 2006/06/22 09:00
PHST- 2006/06/22 09:00 [pubmed]
PHST- 2006/09/13 09:00 [medline]
PHST- 2006/06/22 09:00 [entrez]
AID - MDOI-RMR-06-2006-23-3-0761-8425-101019-200518635 [pii]
AID - 10.1016/s0761-8425(06)71575-3 [doi]
PST - ppublish
SO  - Rev Mal Respir. 2006 Jun;23(3 Pt 1):255-63. doi: 10.1016/s0761-8425(06)71575-3.